Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Guenaga

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Immunity|May 18, 2017
Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap ApproachPaola Martinez-Murillo, Karen Tran, Javier Guenaga, et al.
Nature Communications|March 29, 2017
Global site-specific N-glycosylation analysis of HIV envelope glycoproteinLiwei Cao, Jolene K Diedrich, Daniel W Kulp, et al.
Nature Communications|September 14, 2018
Differential processing of HIV envelope glycans on the virus and soluble recombinant trimerLiwei Cao, Matthias Pauthner, Raiees Andrabi, et al.
NPJ Vaccines|August 20, 2025
Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysisShridhar Bale, Elena Gustchina, Javier Guenaga, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
HIV Env trimers elicit NHP apex cross-neutralizing antibodies mimicking human bNAbsJavier Guenaga, Monika Adori, Shridhar Bale, et al.
Nature|April 29, 2026
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apexJavier Guenaga, Monika Ádori, Shridhar Bale, et al.
The Journal of Infectious Diseases|May 13, 2009
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapyElizabeth Nies-Kraske, Timothy W Schacker, David Condoluci, et al.
Immunity|November 17, 2019
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of VulnerabilityViktoriya Dubrovskaya, Karen Tran, Gabriel Ozorowski, et al.
Immunity|May 8, 2025
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimerFabian-Alexander Schleich, Shridhar Bale, Javier Guenaga, et al.
Immunity|June 22, 2017
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized ApproachesMatthias Pauthner, Colin Havenar-Daughton, Devin Sok, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Immunity|May 18, 2017
Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap ApproachPaola Martinez-Murillo, Karen Tran, Javier Guenaga, et al.
Nature Communications|March 29, 2017
Global site-specific N-glycosylation analysis of HIV envelope glycoproteinLiwei Cao, Jolene K Diedrich, Daniel W Kulp, et al.
Nature Communications|September 14, 2018
Differential processing of HIV envelope glycans on the virus and soluble recombinant trimerLiwei Cao, Matthias Pauthner, Raiees Andrabi, et al.
NPJ Vaccines|August 20, 2025
Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysisShridhar Bale, Elena Gustchina, Javier Guenaga, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
HIV Env trimers elicit NHP apex cross-neutralizing antibodies mimicking human bNAbsJavier Guenaga, Monika Adori, Shridhar Bale, et al.
Nature|April 29, 2026
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apexJavier Guenaga, Monika Ádori, Shridhar Bale, et al.
The Journal of Infectious Diseases|May 13, 2009
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapyElizabeth Nies-Kraske, Timothy W Schacker, David Condoluci, et al.
Immunity|November 17, 2019
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of VulnerabilityViktoriya Dubrovskaya, Karen Tran, Gabriel Ozorowski, et al.
Immunity|May 8, 2025
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimerFabian-Alexander Schleich, Shridhar Bale, Javier Guenaga, et al.
Immunity|June 22, 2017
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized ApproachesMatthias Pauthner, Colin Havenar-Daughton, Devin Sok, et al.
Pageof 6